NVCR: NovoCure Ltd Company Profile & Statistics

About

NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands.

Info & Links

CEO

Asaf Danziger

Headquarters

NO. 4 THE FORUM, GRENVILLE STREET
ST. HELIER, Y9 JE2 4UF, JERSEY

Auditor

KOST FORER GABBAY & KASIERER

Share holders

Employees

1,453

NovoCure Ltd Statistics

Valuation Measures

Market Capitalization²

3.45B

Enterprise Value

3.92B

Enterprise Value/EBITDA(ttm)

-22.47

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

6.26

Price to Book(mrq)

10.02

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

76.37%

Operating Margin(ttm)

-25.93%

Profit Margin(ttm)

-26.27%

Return on Equity(ttm)

-41.48%

Return on Invested Capital(ttm)

-19.19%

Return on Assets(ttm)

-12.74%

Income Statement

Revenue(ttm)

577.74M

Revenue Per Share(ttm)

5.34

Gross Profit(ttm)

441.47M

EBITDA(ttm)³

-174.29M

Net Income Available to Common(ttm)

-149.78M

Diluted EPS(ttm)

-1.40

Share Statistics

Beta (5Y Monthly)

0.75

52-Week Change

145.57%

S&P 500 52-Week Change

25.75%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

108.20M

Dividend Yield

0.00%

Float⁴

101.39M

% Held by Insiders

6.29%

% Held by Institutions

84.61%

Balance Sheet

Total Cash(mrq)

963.67M

Total Cash Per Share(mrq)

8.91

Total Debt(mrq)

654.48M

Total Debt/Equity(mrq)

181.41%

Current Ratio(mrq)

1.49%

Quick Ratio(mrq)

1.44%

Book Value Per Share(mrq)

3.34

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.21

Free Cash Flow(ytd)

-56.83M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

NVCR

NovoCure Ltd

NovoCure Ltd Profile